Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53

Biochemical and Biophysical Research Communications

Volumn 335, Issue 4, 2005, Pages 1272-1279

  Zhu, Ningxi ^a   Gu, Lubing ^a   Findley, Harry W ^a   Zhou, Muxiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c myc; eIF4E; Leukemia; p53

Indexed keywords

INITIATION FACTOR 4E; PROTEIN P53;

ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; WILD TYPE;

CELL LINE, TUMOR; CHILD; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA;

EID: 24044529785     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.026     Document Type: Article

References (30)

1. R.E. Rhoads, S. Joshi-Barve, and C. Rinker-Schaeffer Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis Prog. Nucleic Acid Res. Mol. Biol. 46 1993 183 219
2. S.G. Zimmer, A. DeBenedetti, and J.R. Graff Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis Anticancer Res. 20 2000 1343 1351
3. H.K. Lai, and K.L. Borde The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA Oncogene 19 2000 1623 1634
4. S. Strudwick, and K.L. Borden The emerging roles of translation factor eIF4E in the nucleus Differentiation 70 2002 10 22
5. I. Topisirovic, M.L. Guzman, M.J. McConnell, J.D. Licht, B. Culjkovic, S.J. Neering, C.T. Jordan, and K.L. Borden Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis Mol. Cell. Biol. 23 2003 8992 9002
6. S. Li, T. Takasu, D.M. Perlman, M.S. Peterson, D. Burrichter, S. Avdulov, P.B. Bitterman, and V.A. Polunovsky Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release J. Biol. Chem. 278 2003 3015 3022
7. S. Li, D.M. Perlman, M.S. Peterson, D. Burrichter, S. Avdulov, V.A. Polunovsky, and P.B. Bitterman Translation initiation factor 4E blocks endoplasmic reticulum-mediated apoptosis J. Biol. Chem. 279 2004 21312 21317
8. D. Ruggero, L. Montanaro, L. Ma, W. Xu, P. Londei, C. Cordon-Cardo, and P.P. Pandolfi The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis Nat. Med. 10 2004 484 486
9. A. De Benedetti, and J.R. Graff eIF-4E expression and its role in malignancies and metastases Oncogene 23 2004 3189 3199
10. C.A. Nathan, L. Liu, B.D. Li, F.W. Abreo, I. Nandy, and A. De Benedetti Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer Oncogene 15 1997 579 584
11. C.A. Nathan, N. Amirghahri, C. Rice, F.W. Abreo, R. Shi, and F.J. Stucker Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients Laryngoscope 112 2002 2129 2140
12. B.D. Li, J.C. McDonald, R. Nassar, and A. De Benedetti Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression Ann. Surg. 227 1998 756 763
13. B.D. Li, J.S. Gruner, F. Abreo, L.W. Johnson, H. Yu, S. Nawas, J.C. McDonald, and A. DeBenedetti Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome Ann. Surg. 235 2002 732 739
14. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
15. M.B. Kastan, Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia Cell 71 1992 587 597
16. W.S. el-Deiry, J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, and B. Vogelstein WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res. 54 1994 1169 1174
17. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
18. K. Krause, M. Wasner, W. Reinhard, U. Haugwitz, C.L. Dohna, J. Mossner, and K. Engeland The tumour suppressor protein p53 can repress transcription of cyclin B Nucleic Acids Res. 28 2000 4410 4418
19. A.C. Chun, and D.Y. Jin Transcriptional regulation of mitotic checkpoint gene MAD1 by p53 J. Biol. Chem. 278 2003 37439 37450
20. W.H. Hoffman, S. Biade, J.T. Zilfou, J. Chen, and M. Murphy Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J. Biol. Chem. 277 2002 3247 3257
21. C.A. Nathan, K. Sanders, F.W. Abreo, R. Nassar, and J. Glass Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications Cancer Res. 60 2000 3599 3604
22. R.M. Jones, J. Branda, K.A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E.V. Schmidt An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc Mol. Cell. Biol. 16 1996 4754 4764
23. M. Zhou, A.M. Yeager, S.D. Smith, and H.W. Findley Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene Blood 85 1995 1608 1614
24. W. Zhang, X.Y. Guo, G.Y. Hu, W.B. Liu, J.W. Shay, and A.B. Deisseroth A temperature-sensitive mutant p53 EMBO J. 13 1994 2535 2544
25. D. Ginsberg, F. Mechta, M. Yaniv, and M. Oren Wild-type p53 can down-modulate the activity of various promoters Proc. Natl. Acad. Sci. USA 88 1991 9979 9983
26. L. Gu, N. Zhu, H.W. Findley, W. Woods, and M. Zhou Identification and characterization of the IKKα promoter: positive and negative regulation by Ets-1 and p53, respectively J. Biol. Chem. 279 2004 52141 52149
27. cipi cdk inhibitor influences the outcome of the p53 response to DNA damage Nature 419 2002 729 734
28. W.W. Marhin, S. Chen, L.M. Facchini, A.J. Fornace Jr., and L.Z. Penn Myc represses the growth arrest gene gadd45 Oncogene 14 1997 2825 2834
29. X.Y. Yin, L. Grove, N.S. Datta, K. Katula, M.W. Long, and E.V. Prochownik Inverse regulation of cyclin B1 by c-myc and p53 and induction of tetraploidy by cyclin B1 overexpression Cancer Res. 61 2001 6487 6493
30. A. Bush, M. Mateyak, K. Dugan, A. Obaya, S. Adachi, J. Sedivy, and M. Cole c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets Genes Dev. 12 1998 3797 3802